
1. mol biotechnol. 2020 oct;62(10):534-545. doi: 10.1007/s12033-020-00271-x. epub
2020 sep 1.

an ama1/msp119 adjuvanted malaria transplastomic plant-based vaccine induces
immune responses test animals.

milán-noris em(1)(2), monreal-escalante e(3), rosales-mendoza s(4), soria-guerra 
re(5), radwan o(6)(7), juvik ja(1)(8), korban ss(9)(10).

author information: 
(1)division nutritional sciences, university illinois urbana-champaign, 
urbana, il, 61801, usa.
(2)facultad de ciencias químico biológicas, universidad autónoma de sinaloa,
culiacán, sinaloa, mexico.
(3)laboratorio de biofarmacéuticos recombinantes, facultad de ciencias químicas, 
universidad autónoma de san luis potosí, av. dr. manuel nava 6, 78210, san luis
potosi, slp, mexico.
(4)laboratorio de biofarmacéuticos recombinantes, facultad de ciencias químicas, 
universidad autónoma de san luis potosí, av. dr. manuel nava 6, 78210, san luis
potosi, slp, mexico. rosales.s@fcq.uaslp.mx.
(5)laboratorio de ingeniería de biorreactores, facultad de ciencias químicas,
universidad autónoma de san luis potosí, av. dr. manuel nava 6, 78210, san luis
potosi, slp, mexico.
(6)department natural resources environmental sciences, university of
illinois urbana-champaign, urbana, il, 61801, usa.
(7)environmental microbiology group, university dayton, dayton, oh, 45469,
usa.
(8)department crop sciences, university illinois urbana-champaign,
urbana, il, 61801, usa.
(9)division nutritional sciences, university illinois urbana-champaign, 
urbana, il, 61801, usa. korban@illinois.edu.
(10)department natural resources environmental sciences, university of
illinois urbana-champaign, urbana, il, 61801, usa. korban@illinois.edu.

malaria tropical human disease, caused protozoan parasites, wherein a
significant number world's population risk. annually, 219 
million new cases reported. although prevention treatments, there
are highly widely effective licensed anti-malarial vaccines available 
use. opportunities utilization plant-based vaccines novel platforms for
developing safe, reliable, affordable treatments offer promise developing
such vaccine malaria. study, malchloroplast candidate vaccine
was designed, composed segments ama1 msp1 proteins, two epitopes of
plasmodium falciparum, along gk1 peptide taenia solium adjuvant,
and expressed tobacco chloroplasts. transplastomic tobacco lines were
generated using biolistic transformation, confirmed carry the
synthetic gene construct. expression synthetic gk1 peptide confirmed
using rt-pcr western blots. furthermore, gk1 peptide detected hplc
at levels 6 µg g-1 dry weight tobacco leaf tissue. plant-derived 
malchloroplast candidate vaccine subsequently tested balb/c female mice
following subcutaneous administration, found elicit specific humoral
responses. furthermore, components candidate vaccine recognized by
antibodies plasmodium falciparum malaria patients immunogenic test
mice. thus, study provided 'proof concept' promising plant-based 
candidate subunit vaccine malaria.

doi: 10.1007/s12033-020-00271-x 
pmid: 32870446 

